Royal Philips (PHG) and Medtronic Neurovascular announced a strategic advocacy partnership. As leaders in stroke diagnosis and treatment, the two organizations are advocating on raising awareness around the potential health and economic benefits for patients, their families and societies of improving access to timely stroke diagnosis and treatment.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHG:
- Philips showcases next level cardiology innovations at TCT 2024
- Philips upgraded to Outperform from Neutral at Oddo BHF
- Philips, Siloam Hospitals Group sign AI capability MoU
- Philips price target raised to EUR 28.50 from EUR 26.50 at Citi
- Philips, Jackson Health System announces results of collaborative LCA